Dynamic Interaction between a Millimeter-Sized Bubble and Surface Microbubbles in Water by Bo Liu (127343)

“…Furthermore, our results suggest that smaller surface bubbles (30–100 μm) are more effective for the attachment onto a large bubble as the coalescence time decreases considerably when the microbubbles are smaller than 100 μm.…”

Pharmacologically induced torpor by 5′-AMP does not decrease platelet count despite decreased body temperature. by Edwin L. de Vrij (550179)

“…<p>A) Pharmacologically induced torpor by 5′-AMP in mice does not decrease platelet count during torpor and shows an increase upon arousal. …”

Structure of P-YOLOv5s-GRNF. by Zhongjian Xie (4633099)

STAT6 siRNA sequential transfection is effective in maintaining a reduced number of HT-29 cells. by Carmen Salguero-Aranda (6690044)

Subjects:

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. by Ping-yu Cai (12389929)

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…CRT in the recurrence group significantly decreased from 546.1 ± 117.0 μm preoperatively to 317.1 ± 46.9, 317.8 ± 55.6, 290.8 ± 33.5, 342.9 ± 82.2, 333.0 ± 84.2, and 349.8 ± 76.9 μm at 1, 3, 6, 12, 24, and 36 months postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

Fig 5 - by Jacob C. Jentzer (4746999)

miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE^-/- mice. by Ping-yu Cai (12389929)

Mean and standard deviation of vascular density. by Beatriz Cordon (9745619)

Mean and standard deviation of vascular density. by Beatriz Cordon (9745619)

Mean and standard deviation of vascular density. by Beatriz Cordon (9745619)

Mean and standard deviation of vascular density. by Beatriz Cordon (9745619)

(a) Schematic of the sample preparation, (b) developed GFRPs samples modified, (c) samples for impact strength tests, (d) samples for compressive strength tests. by Shaban Gul (14309526)

Subjects:

Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases V1V2-specific IgG concentration and breadth. by LaTonya D. Williams (3140490)

Rescue of <i>MBNL</i>1 e5 and <i>MBNL</i>2 e5 and e8 mis-splicing by erythromycin lactobionate treatment at 10 DPI. by Mougina K. Eltahir (12988153)

“…Note the decreased inclusion of <i>MBNL</i>1 e5 (+e5) and <i>MBNL</i>2 e5 (+e5) in DM1 hiNeurons treated with 35 or 65 μM erythromycin for 48 h relative to placebo treated cells. …”

Mean-difference plots by country: Countries with decreased variance and no change in mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

Mean-difference plots by country: Countries with decreased variance and increased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

Mean-difference plots by country: Countries with increased variance and decreased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

Mean-difference plots by country: Countries with no change in variance and decreased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)